Hired someone new and exciting? Promoting a rising star? Finally solved that hard-to-fill spot?Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going.
And here is our regular feature in which we highlight a different person each week. This time around, we note that Actinium Pharmaceuticals (ATNM) hired Anil Kapur as chief commercial officer. Most recently, he worked for the past year and a half at Bristol-Myers Squibb, where he was vice president, head of early assets, biomarkers and external innovation in worldwide oncology commercialization.
About the Author Reprints
